Takaisin Tulosta

Tyypin 2 diabetes, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
18.3.2024
  • Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Tyypin 2 diabetes «Tyypin 2 diabetes»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Agarwal R, Filippatos G, Pitt B, ym. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J 2022;43(6):474-484 «PMID: 35023547»PubMed
  2. AHA, ACC, National Heart, Lung, and Blood Institute, ym. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006;47(10):2130-9 «PMID: 16697342»PubMed
  3. Ajjan R. Real world benefits of Flash Glucose Monitoring in a multinational database. Lecture in ATTD congress 2017, Paris
  4. Bergenstal RM, Bailey TS, Rodbard D, ym. Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections. Diabetes Care 2017;40(4):554-560 «PMID: 28115474»PubMed
  5. Bilir SP, Hellmund R, Wehler B, ym. Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden. Eur Endocrinol 2018;14(2):73-79 «PMID: 30349598»PubMed
  6. Bilir SP, Hellmund R, Wehler E, ym. The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden. Eur Endocrinol 2018;14(2):80-85 «PMID: 30349599»PubMed
  7. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, ym. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016;388(10057):2254-2263 «PMID: 27634581»PubMed
  8. Bueno NB, de Melo IS, de Oliveira SL, ym. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr 2013;110(7):1178-87 «PMID: 23651522»PubMed
  9. Cannon CP, Braunwald E, McCabe CH, ym. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350(15):1495-504 «PMID: 15007110»PubMed
  10. Cannon CP, Steinberg BA, Murphy SA, ym. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006;48(3):438-45 «PMID: 16875966»PubMed
  11. Chong K, Ikramuddin S, Lee WJ, ym. National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m(2)). Obes Surg 2017;27(5):1189-1195 «PMID: 27783367»PubMed
  12. Clifton PM, Condo D, Keogh JB. Long term weight maintenance after advice to consume low carbohydrate, higher protein diets--a systematic review and meta analysis. Nutr Metab Cardiovasc Dis 2014;24(3):224-35 «PMID: 24472635»PubMed
  13. Correction to Lancet Diabetes Endocrinol 2018; 6: 954-65. Lancet Diabetes Endocrinol 2019;7(3):e3 «PMID: 30782470»PubMed
  14. Courcoulas AP, Belle SH, Neiberg RH, ym. Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial. JAMA Surg 2015;150(10):931-40 «PMID: 26132586»PubMed
  15. D'Aiuto F, Gkranias N, Bhowruth D, ym. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol 2018;6(12):954-965 «PMID: 30472992»PubMed
  16. Davies MJ, Gross JL, Ono Y, ym. Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial. Diabetes Obes Metab 2014;16(10):922-30 «PMID: 24702700»PubMed
  17. de Lemos JA, Blazing MA, Wiviott SD, ym. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004;292(11):1307-16 «PMID: 15337732»PubMed
  18. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, ym. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-86 «PMID: 8366922»PubMed
  19. Dyck PJ, Davies JL, Wilson DM, ym. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999;22(9):1479-86 «PMID: 10480512»PubMed
  20. Dyck PJ, Kratz KM, Karnes JL, ym. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43(4):817-24 «PMID: 8469345»PubMed
  21. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):854-65 «PMID: 9742977»PubMed
  22. Evans M, Welsh Z, Ells S ym. The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies. Diabetes Ther 2020;11:83-95
  23. Filippatos G, Anker SD, Agarwal R, ym. Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes. Circulation 2021;143(6):540-552 «PMID: 33198491»PubMed
  24. Garber AJ, King AB, Del Prato S, ym. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet 2012;379(9825):1498-507 «PMID: 22521072»PubMed
  25. Haak T, Hanaire H, Ajjan R, ym. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial. Diabetes Ther 2017;8(1):55-73 «PMID: 28000140»PubMed
  26. Heller S, Buse J, Fisher M, ym. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet 2012;379(9825):1489-97 «PMID: 22521071»PubMed
  27. Hellmund R, Weitgasser R, Blissett D. Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin - a UK Perspective. Eur Endocrinol 2018;14(2):86-92 «PMID: 30349600»PubMed
  28. Holman RR, Paul SK, Bethel MA, ym. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359(15):1577-89 «PMID: 18784090»PubMed
  29. Home PD, Bergenstal RM, Bolli GB, ym. New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4). Diabetes Care 2015;38(12):2217-25 «PMID: 26084341»PubMed
  30. Homko CJ, Duffy F, Friedenberg FK, ym. Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis. Neurogastroenterol Motil 2015;27(4):501-8 «PMID: 25600163»PubMed
  31. Hsu CC, Almulaifi A, Chen JC, ym. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes. JAMA Surg 2015;150(12):1117-24 «PMID: 26374954»PubMed
  32. Ikramuddin S, Korner J, Lee WJ, ym. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial. Diabetes Care 2016;39(9):1510-8 «PMID: 27311493»PubMed
  33. Ikramuddin S, Korner J, Lee WJ, ym. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA 2018;319(3):266-278 «PMID: 29340678»PubMed
  34. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53 «PMID: 9742976»PubMed
  35. Johnston BC, Kanters S, Bandayrel K, ym. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 2014;312(9):923-33 «PMID: 25182101»PubMed
  36. Knowler WC, Barrett-Connor E, Fowler SE, ym. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403 «PMID: 11832527»PubMed
  37. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005;67(2):152-62 «PMID: 15649575»PubMed
  38. LaRosa JC, Grundy SM, Waters DD, ym. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352(14):1425-35 «PMID: 15755765»PubMed
  39. Lind M, Imberg H, Coleman RL, ym. Historical HbA(1c) Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care 2021;44(10):2231-7 «PMID: 34244332»PubMed
  40. Lindström J, Ilanne-Parikka P, Peltonen M, ym. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368(9548):1673-9 «PMID: 17098085»PubMed
  41. Liu Q, Li S, Quan H, ym. Vitamin B12 status in metformin treated patients: systematic review. PLoS One 2014;9(6):e100379 «PMID: 24959880»PubMed
  42. Maiz C, Alvarado J, Quezada N ym. Bariatric surgery in 1119 patients with preoperative body mass index<35 (kg/m(2)): results at 1 year. Surg Obes Relat Dis 2015;11:1127-32
  43. Mansoor N, Vinknes KJ, Veierød MB, ym. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br J Nutr 2016;115(3):466-79 «PMID: 26768850»PubMed
  44. Maruyama T, Shimada A, Kanatsuka A ym. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. Ann N Y Acad Sci 2003;1005:362-9
  45. Matsuhisa M, Koyama M, Cheng X, ym. New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1). Diabetes Obes Metab 2016;18(4):375-83 «PMID: 26662964»PubMed
  46. Mingrone G, Panunzi S, De Gaetano A, ym. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015;386(9997):964-73 «PMID: 26369473»PubMed
  47. Müller-Stich BP, Senft JD, Warschkow R, ym. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg 2015;261(3):421-9 «PMID: 25405560»PubMed
  48. Nathan DM, Cleary PA, Backlund JY, ym. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353(25):2643-53 «PMID: 16371630»PubMed
  49. Nathanson D, Svensson AM, Miftaraj M, ym. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. Diabetologia 2021;64(7):1595-1603 «PMID: 33774713»PubMed
  50. Naude CE, Schoonees A, Senekal M, ym. Low carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysis. PLoS One 2014;9(7):e100652 «PMID: 25007189»PubMed
  51. Niafar M, Hai F, Porhomayon J, ym. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Intern Emerg Med 2015;10(1):93-102 «PMID: 25502588»PubMed
  52. Niskanen LK, Tuomi T, Karjalainen J, ym. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis. Diabetes Care 1995;18(12):1557-65 «PMID: 8722051»PubMed
  53. Ohkubo Y, Kishikawa H, Araki E, ym. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28(2):103-17 «PMID: 7587918»PubMed
  54. O'Keefe JH Jr, Cordain L, Harris WH, ym. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 2004;43(11):2142-6 «PMID: 15172426»PubMed
  55. Olausson EA, Alpsten M, Larsson A, ym. Small particle size of a solid meal increases gastric emptying and late postprandial glycaemic response in diabetic subjects with gastroparesis. Diabetes Res Clin Pract 2008;80(2):231-7 «PMID: 18237818»PubMed
  56. Olausson EA, Störsrud S, Grundin H, ym. A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial. Am J Gastroenterol 2014;109(3):375-85 «PMID: 24419482»PubMed
  57. Palomäki A , Kovanen P. LDL-kolesterolin luonnonmukainen pitoisuus on saavutettavissa turvallisesti. Duodecim 2006;122;1747-56
  58. Parikh M, Chung M, Sheth S, ym. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg 2014;260(4):617-22; discussion 622-4 «PMID: 25203878»PubMed
  59. Pedersen TR, Faergeman O, Kastelein JJ, ym. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005;294(19):2437-45 «PMID: 16287954»PubMed
  60. Pitt B, Filippatos G, Agarwal R, ym. Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N Engl J Med 2021;385(24):2252-2263 «PMID: 34449181»PubMed
  61. Ramachandran A, Snehalatha C, Mary S ym. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006;49:289-97
  62. Reddy M, Jugnee N, Anantharaja S, ym. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study. Diabetes Technol Ther 2018;20(11):751-757 «PMID: 30265562»PubMed
  63. Riddle MC, Bolli GB, Ziemen M, ym. New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1). Diabetes Care 2014;37(10):2755-62 «PMID: 25078900»PubMed
  64. Roussel R, Riveline JP, Vicaut E, ym. Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study. Diabetes Care 2021;44(6):1368-1376 «PMID: 33879536»PubMed
  65. Schauer PR, Bhatt DL, Kirwan JP, ym. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med 2017;376(7):641-651 «PMID: 28199805»PubMed
  66. Simpson TC, Clarkson JE, Worthington HV, ym. Treatment of periodontitis for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev 2022;4(4):CD004714 «PMID: 35420698»PubMed
  67. Suarez GA, Clark VM, Norell JE, ym. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry 2005;76(2):240-5 «PMID: 15654040»PubMed
  68. Tesfaye S, Chaturvedi N, Eaton SE, ym. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352(4):341-50 «PMID: 15673800»PubMed
  69. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group. Ann Intern Med 1995;122(8):561-8 «PMID: 7887548»PubMed
  70. Thomas D, Elliott EJ. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst Rev 2009;2009(1):CD006296 «PMID: 19160276»PubMed
  71. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317(7160):703-13 «PMID: 9732337»PubMed
  72. Tobias DK, Chen M, Manson JE, ym. Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015;3(12):968-79 «PMID: 26527511»PubMed
  73. Tuomilehto J, Lindström J, Eriksson JG, ym. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344(18):1343-50 «PMID: 11333990»PubMed
  74. Turner R, Stratton I, Horton V, ym. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997;350(9087):1288-93 «PMID: 9357409»PubMed
  75. Tyndall V, Stimson RH, Zammitt NN, ym. Marked improvement in HbA(1c) following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia 2019;62(8):1349-1356 «PMID: 31177314»PubMed
  76. van Mark G, Lanzinger S, Barion R, ym. Patient and disease characteristics of adult patients with type 1 diabetes in Germany: an analysis of the DPV and DIVE databases. Ther Adv Endocrinol Metab 2019;10():2042018819830867 «PMID: 30834104»PubMed
  77. Wheeler ML, Dunbar SA, Jaacks LM, ym. Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010. Diabetes Care 2012;35(2):434-45 «PMID: 22275443»PubMed
  78. Wiviott SD, Cannon CP, Morrow DA, ym. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. J Am Coll Cardiol 2005;46(8):1411-6 «PMID: 16226163»PubMed
Artikkelin tunnus: nix03358 (050.056)
© 2025 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit